Lab Information

Jesse Papenburg (MD)

Scientist
Centre for Outcomes Research and Evaluation
Department of Pediatrics (McGill)

Research Profile

 Fundamental: 10%
 Clinical: 20%
 Epidemiology: 60%
 Evaluation: 10%
 This email address is being protected from spambots. You need JavaScript enabled to view it.

Keywords

Influenza • respiratory syncytial virus (RSV) • children • epidemiology • diagnosis

Research Interests

My research focuses on the epidemiology and diagnosis of severe viral lower respiratory tract infections requiring hospitalisation in children in Quebec and Canada.


Team Members

Name Position

Latest Publications

  1. Langedijk, A. C., Vrancken, B., Lebbink, R. J., Wilkins, D., Kelly, E. J., Baraldi, E., Mascareñas de Los Santos, A. H., Danilenko, D. M., Choi, E. H., Palomino, M. A., Chi, H., Keller, C., Cohen, R., Papenburg, J., Pernica, J., Greenough, A., Richmond, P., Martinón-Torres, F., Heikkinen, T., Stein, R. T., Hosoya, M., Nunes, M. C., Verwey, C., Evers, A., Kragten-Tabatabaie, L., Suchard, M. A., Kosakovsky Pond, S. L., Poletto, C., Colizza, V., Lemey, P., Bont, L. J. & INFORM-RSV Study Group (2024). The genomic evolutionary dynamics and global circulation patterns of respiratory syncytial virus. Nature communications, vol. 15, p. 3083.
  2. Sinilaite, A., Siu, W. & Papenburg, J. (2023). Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023-2024. Canada communicable disease report = Releve des maladies transmissibles au Canada, vol. 49, p. 406-412.
  3. Schober, T., Wong, K., DeLisle, G., Caya, C., Brendish, N. J., Clark, T. W., Dendukuri, N., Doan, Q., Fontela, P. S., Gore, G. C., Li, P., McGeer, A. J., Noël, K. C., Robinson, J. L., Suarthana, E. & Papenburg, J. (2024). Clinical Outcomes of Rapid Respiratory Virus Testing in Emergency Departments: A Systematic Review and Meta-Analysis. JAMA internal medicine.
  4. Farrar, D., Hepburn, C. M., Drouin, O., El Tal, T., Morin, M.-P., Berard, R., King, M., Thibodeau, M. L., Baerg, K., Beaudoin-Bussières, G., Beaufils, C., Bennett, T.-L., Benseler, S., Chan, K., Cyr, C., Dahdah, N., Donner, E., Embree, J., Farrell, C., Finzi, A., Forgie, S., Giroux, R., Kang, K., Lang, B., Laxer, R., McCrindle, B., Orkin, J., Papenburg, J., Pound, C., Price, V., Proulx-Gauthier, J.-P., Purewal, R., Sadarangani, M., Salvadori, M., Thibeault, R., Top, K., Viel-Thériault, I., Haddad, E., Scuccimarri, R., Yeung, R., Kakkar, F. & Morris, S. (2023). Resource use and disease severity of children hospitalized for COVID-19 versus multisystem inflammatory syndrome in children (MIS-C) in Canada. Canada communicable disease report = Releve des maladies transmissibles au Canada, vol. 49, p. 103-112.
  5. Sinilaite, A., Young, K. & Papenburg, J. (2023). Summary of the National Advisory Committee on Immunization (NACI) Statement-Recommendation on Repeated Seasonal Influenza Vaccination. Canada communicable disease report = Releve des maladies transmissibles au Canada, vol. 49, p. 99-102.
  6. Robinson, J. L. & Papenburg, J. (2023). The rapidly changing landscape of respiratory syncytial virus prophylaxis. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 8, p. 165-171.
  7. Harrison, R., Mubareka, S., Papenburg, J., Schober, T., Allen, U. D., Hatchette, T. F. & Evans, G. A. (2023). AMMI Canada 2023 update on influenza: Management and emerging issues. Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada, vol. 8, p. 176-185.
  8. Modler, J., Morris, S. K., Bettinger, J. A., Bancej, C., Burton, C., Foo, C., Halperin, S. A., Jadavji, T., Kazmi, K., Sadarangani, M., Schober, T., Papenburg, J. & Canadian Immunization Monitoring Program Active (IMPACT) Investigators (2024). Bloodstream Infections in Children Hospitalized for Influenza, the Canadian Immunization Monitoring Program Active (IMPACT). The Pediatric infectious disease journal, vol. 43, p. 301-306.
  9. Schober, T., Morris, S. K., Bettinger, J. A., Burton, C., Halperin, S. A., Jadavji, T., Kazmi, K., Modler, J., Sadarangani, M., Papenburg, J. & Canadian Immunization Monitoring Program Active (IMPACT) Investigators (2023). Antibiotic use in children hospitalised for influenza, 2010-2021: the Canadian Immunization Monitoring Program Active (IMPACT). Infection.
  10. Camirand Lemyre, F., Honfo, S. H., Caya, C., Cheng, M. P., Colwill, K., Corsini, R., Gingras, A.-C., Jassem, A., Krajden, M., Márquez, A. C., Mazer, B. D., McLennan, M., Renaud, C., Yansouni, C. P., Papenburg, J. & Lewin, A. (2023). Two-phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID-19 serological assays as a proof of concept. Vox sanguinis, vol. 118, p. 1069-1077.
More on PubMed 



See also

Card image
Matthew
Cheng


See profile
Card image
Cédric
Yansouni


See profile
Card image
Marie-Astrid
Lefebvre


See profile
Card image
Nandini
Dendukuri


See profile
Card image
Makeda
Semret


See profile
Card image
Michael
Libman


See profile